BSE Live
Jan 22, 16:01Prev. Close
1612.55
Open Price
1613.00
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Jan 22, 15:59Prev. Close
1612.90
Open Price
1614.10
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
1634.20 (261)
| Balance Sheet of Sun Pharmaceutical Industries (in Rs. Cr.) | Mar 15 | Mar 14 | Mar 13 | Mar 12 | Mar 11 | |
| 12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
| EQUITIES AND LIABILITIES | ||||||
| SHAREHOLDER'S FUNDS | ||||||
| Equity Share Capital | 207.12 | 207.12 | 103.56 | 103.56 | 103.56 | |
| Total Share Capital | 207.12 | 207.12 | 103.56 | 103.56 | 103.56 | |
| Reserves and Surplus | 22,530.77 | 7,200.76 | 7,685.32 | 7,774.56 | 6,576.97 | |
| Total Reserves and Surplus | 22,530.77 | 7,200.76 | 7,685.32 | 7,774.56 | 6,576.97 | |
| Total Shareholders Funds | 22,737.89 | 7,407.88 | 7,788.88 | 7,878.12 | 6,680.53 | |
| NON-CURRENT LIABILITIES | ||||||
| Long Term Borrowings | 1,170.32 | 4.64 | 4.64 | 0.00 | 0.00 | |
| Deferred Tax Liabilities [Net] | 0.00 | 192.84 | 165.41 | 133.91 | 128.51 | |
| Other Long Term Liabilities | 14.37 | 1.38 | 1.01 | 2.03 | 2.19 | |
| Long Term Provisions | 2,422.51 | 2,524.19 | 131.49 | 98.62 | 8.68 | |
| Total Non-Current Liabilities | 3,607.20 | 2,723.05 | 302.55 | 234.56 | 139.38 | |
| CURRENT LIABILITIES | ||||||
| Short Term Borrowings | 4,252.81 | 2,404.37 | 38.49 | 40.30 | 50.53 | |
| Trade Payables | 1,485.03 | 380.06 | 363.27 | 400.19 | 269.66 | |
| Other Current Liabilities | 3,247.55 | 233.61 | 145.15 | 62.54 | 42.08 | |
| Short Term Provisions | 2,066.69 | 688.03 | 608.15 | 515.49 | 424.42 | |
| Total Current Liabilities | 11,052.08 | 3,706.07 | 1,155.06 | 1,018.52 | 786.69 | |
| Total Capital And Liabilities | 37,445.55 | 13,837.00 | 9,246.49 | 9,131.20 | 7,606.60 | |
| ASSETS | ||||||
| NON-CURRENT ASSETS | ||||||
| Tangible Assets | 3,115.29 | 1,257.56 | 1,134.76 | 975.93 | 783.18 | |
| Intangible Assets | 69.98 | 9.61 | 1.03 | 1.37 | 11.21 | |
| Capital Work-In-Progress | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Other Assets | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Fixed Assets | 4,275.86 | 1,747.63 | 1,483.83 | 1,226.17 | 990.04 | |
| Non-Current Investments | 25,782.23 | 6,155.73 | 3,376.49 | 3,592.80 | 1,778.59 | |
| Deferred Tax Assets [Net] | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Long Term Loans And Advances | 1,895.23 | 761.49 | 491.09 | 338.54 | 143.89 | |
| Other Non-Current Assets | 41.95 | 0.11 | 7.83 | 2.83 | 0.19 | |
| Total Non-Current Assets | 31,995.27 | 8,664.96 | 5,359.24 | 5,160.34 | 2,912.71 | |
| CURRENT ASSETS | ||||||
| Current Investments | 93.93 | 860.00 | 941.05 | 844.98 | 1,822.83 | |
| Inventories | 2,189.25 | 918.38 | 868.76 | 640.07 | 618.26 | |
| Trade Receivables | 1,802.82 | 452.75 | 737.53 | 713.48 | 542.62 | |
| Cash And Cash Equivalents | 416.46 | 141.48 | 431.12 | 1,327.71 | 1,250.91 | |
| Short Term Loans And Advances | 696.69 | 309.32 | 849.50 | 390.61 | 418.35 | |
| OtherCurrentAssets | 251.13 | 2,490.11 | 59.29 | 54.01 | 40.92 | |
| Total Current Assets | 5,450.28 | 5,172.04 | 3,887.25 | 3,970.86 | 4,693.89 | |
| Total Assets | 37,445.55 | 13,837.00 | 9,246.49 | 9,131.20 | 7,606.60 | |
| OTHER ADDITIONAL INFORMATION | ||||||
| CONTINGENT LIABILITIES, COMMITMENTS | ||||||
| Contingent Liabilities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| CIF VALUE OF IMPORTS | ||||||
| Raw Materials | 632.32 | 289.47 | 269.20 | 289.52 | 258.58 | |
| Stores, Spares And Loose Tools | 151.09 | 90.08 | 94.44 | 66.90 | 33.73 | |
| Trade/Other Goods | 151.09 | 90.08 | 94.44 | 66.90 | 33.73 | |
| Capital Goods | 363.66 | 148.94 | 121.76 | 90.78 | 90.35 | |
| EXPENDITURE IN FOREIGN EXCHANGE | ||||||
| Expenditure In Foreign Currency | 1,333.44 | 684.99 | 252.40 | 154.94 | 111.71 | |
| REMITTANCES IN FOREIGN CURRENCIES FOR DIVIDENDS | ||||||
| Dividend Remittance In Foreign Currency | -- | -- | -- | -- | -- | |
| EARNINGS IN FOREIGN EXCHANGE | ||||||
| FOB Value Of Goods | 4,623.50 | 2,271.33 | 1,923.80 | 1,462.82 | 896.36 | |
| Other Earnings | 247.05 | 45.47 | 37.72 | 1.77 | 4.20 | |
| BONUS DETAILS | ||||||
| Bonus Equity Share Capital | 184.37 | 184.37 | 80.82 | 80.82 | 80.82 | |
| NON-CURRENT INVESTMENTS | ||||||
| Non-Current Investments Quoted Market Value | 72.98 | 63.97 | 66.60 | 63.27 | 233.27 | |
| Non-Current Investments Unquoted Book Value | 26,370.49 | 6,094.00 | 3,314.76 | 3,531.07 | 1,710.95 | |
| CURRENT INVESTMENTS | ||||||
| Current Investments Quoted Market Value | 9.34 | -- | -- | 12.09 | 34.60 | |
| Current Investments Unquoted Book Value | 85.00 | 860.00 | 941.05 | 832.73 | 1,787.83 |
07.01.2026
20.11.2025
12.11.2025
11.11.2025
Buy Sun Pharmaceutical Industries; target of Rs 1875 Prabhudas Lilladher
11.11.2025
Sun Pharma Standalone September 2025 Net Sales at Rs 4,548.11 crore, down 11.3% Y-o-Y
01.08.2025
Sun Pharma Consolidated June 2025 Net Sales at Rs 13,851.40 crore, up 9.47% Y-o-Y
31.07.2025
Sun Pharma Standalone June 2025 Net Sales at Rs 5,601.96 crore, up 24.54% Y-o-Y
22.05.2025
Sun Pharma Q4 net profit declines 19% to Rs 2,154 crore, firm declares Rs 5.50 dividend